Pharmacokinetics of an increased atazanavir dose with and without tenofovir during the third trimester of pregnancy

Pharmacokinetics of an increased atazanavir dose with and without tenofovir during the third trimester of pregnancy

BACKGROUND: Reduced atazanavir exposure has been demonstrated during pregnancy with standard atazanavir/ritonavir dosing. We studied an increased dose during the third trimester of pregnancy. METHODS: International Maternal Pediatric Adolescent AIDS Clinical Trials Group 1026s is a prospective, nonb...

Saved in:

書目詳細資料
Main Authors:	Regis Kreitchmann, Brookie M. Best, Jiajia Wang, Alice Stek, Edmund Caparelli, D. Heather Watts, Elizabeth Smith, David E. Shapiro, Steve Rossi, Sandra K. Burchett, Elizabeth Hawkins, Mark Byroads, Tim R. Cressey, Mark Mirochnick
格式:	雜誌
出版:	2018
主題:	Medicine
在線閱讀:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84876294301&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/52877
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Pharmacokinetics of an increased atazanavir dose with and without tenofovir during the third trimester of pregnancy
由: Regis Kreitchmann, et al.
出版: (2018)

Raltegravir pharmacokinetics during pregnancy
由: D. Heather Watts, et al.
出版: (2018)

Raltegravir pharmacokinetics during pregnancy
由: D. Heather Watts, et al.
出版: (2018)

Efavirenz pharmacokinetics during pregnancy and infant washout
由: Regis Kreitchmann, et al.
出版: (2019)

Pharmacokinetics of once versus twice daily darunavir in pregnant HIV-infected women
由: Alice Stek, et al.
出版: (2018)

Pharmacokinetics of once versus twice daily darunavir in pregnant HIV-infected women
由: Alice Stek, et al.
出版: (2018)

Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum
由: Tim R. Cressey, et al.
出版: (2018)

Reduced indinavir exposure during pregnancy
由: Tim R. Cressey, et al.
出版: (2018)

Reduced indinavir exposure during pregnancy
由: Tim R. Cressey, et al.
出版: (2018)

Pharmacokinetics of Atazanavir/ritonavir among HIV-infected Thai children concomitantly taking tenofovir disoproxil fumarate
由: Torsak Bunupuradah, et al.
出版: (2018)

Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum
由: Cressey T., et al.
出版: (2017)

Fosamprenavir with Ritonavir Pharmacokinetics during Pregnancy
由: Ahizechukwu C. Eke, et al.
出版: (2020)

External validation of the bilirubin-atazanavir nomogram for assessment of atazanavir plasma exposure in HIV-1-infected patients
由: Dinko Rekić, et al.
出版: (2018)

Pharmacokinetic parameters of atazanavir in ritonavir-boosted combination therapy in Thai healthy volunteers : comparison between reduced doses of ritonavir or atazanavir
由: Chankit Puttilerpong
出版: (2011)

Safety of darunavir and atazanavir in HIV-infected children in Europe and Thailand
由: Heather Bailey, et al.
出版: (2018)

Pharmacokinetics of unboosted atazanavir in treatment-experienced HIV-infected children, adolescents and young adults
由: Cressey T., et al.
出版: (2017)

Pharmacokinetics of unboosted atazanavir in treatment-experienced HIV-infected children, adolescents and young adults
由: Tim R. Cressey, et al.
出版: (2018)

Safety of darunavir and atazanavir in HIV-infected children in Europe and Thailand
由: Bailey H., et al.
出版: (2017)

Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarate
由: Tim R. Cressey, et al.
出版: (2020)

Urine tenofovir concentrations correlate with plasma and relate to tenofovir disoproxil fumarate adherence: A randomized, directly observed pharmacokinetic trial (target study)
由: Paul K. Drain, et al.
出版: (2020)

Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancy
由: Tim R. Cressey, et al.
出版: (2018)

Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancy
由: Tim R. Cressey, et al.
出版: (2018)

Population pharmacokinetics and dose optimisation of ritonavir-boosted atazanavir in Thai HIV-infected patients
由: Baralee Punyawudho, et al.
出版: (2018)

Population pharmacokinetics and dose optimisation of ritonavir-boosted atazanavir in Thai HIV-infected patients
由: Baralee Punyawudho, et al.
出版: (2018)

Population pharmacokinetics and dose optimisation of ritonavir-boosted atazanavir in Thai HIV-infected patients
由: Punyawudho B., et al.
出版: (2017)

Comparison of thai government manufactured tenofovir (Tenofovir GPO300) with privately manufactured tenofovir (Viread) used along with lamivudine and efavirenz to treat Thai HIV patients
由: Weerawat Manosuthi, et al.
出版: (2018)

Association between polymorphisms of tenofovir transporters and tenofovir plasma levels in Thai HIV-infected patients
由: Siwaporn Mitruk
出版: (2013)

Tenofovir Exposure during Pregnancy and Postpartum in Women Receiving Tenofovir Disoproxil Fumarate for the Prevention of Mother-to-Child Transmission of Hepatitis B Virus
由: Tim R. Cressey, et al.
出版: (2018)

Tenofovir versus placebo to prevent perinatal transmission of hepatitis B
由: G. Jourdain, et al.
出版: (2018)

Tenofovir versus placebo to prevent perinatal transmission of hepatitis B
由: G. Jourdain, et al.
出版: (2018)

Tenofovir versus placebo to prevent perinatal transmission of hepatitis B
由: Gonzague Jourdain, et al.
出版: (2018)

Innovative Approaches for Pharmacology Studies in Pregnant and Lactating Women: A Viewpoint and Lessons from HIV
由: Ahizechukwu C. Eke, et al.
出版: (2020)

Review of tenofovir use in HIV-infected children
由: Linda Aurpibul, et al.
出版: (2018)

Review of tenofovir use in HIV-infected children
由: Linda Aurpibul, et al.
出版: (2018)

Tenofovir for children and adults with chronic hepatitis B
由: Li, Huijuan, et al.
出版: (2023)

Pharmacogenetics-based population pharmacokinetic analysis for dose optimization of ritonavir-boosted atazanavir in Thai adult HIV-infected patients
由: Noppaket Singkham, et al.
出版: (2022)

Pharmacogenetics-based population pharmacokinetic analysis for dose optimization of ritonavir-boosted atazanavir in Thai adult HIV-infected patients
由: Singkham N.
出版: (2023)

SAFETY USE OF COMBINATION TENOFOVIR-LAMIVUDINE-DOLUTEGRAVIR COMPARED WITH TENOFOVIR-LAMIVUDINE-EFAVIRENZ IN HIV PATIENTS AT IBRAHIM ADJIE COMMUNITY HEALTH CENTER BANDUNG
由: Zidan Fikri Akromy, Muhammad

EFFECTIVENESS OF TENOFOVIR-LAMIVUDIN-EFAVIRENZ (TLE) COMBINATION COMPARED TO TENOFOVIR-LAMIVUDIN- DOLUTEGRAVIR (TLD) IN HIV PATIENTS AT UPTD PUSKESMAS IBRAHIM ADJIE BANDUNG
由: Basuki

Semester or trimester--?: That is the question
由: Alipao, Noela Lynn, et al.
出版: (1983)